Disposition and metabolism of LY2603618, a Chk-1 inhibitor following intravenous administration in patients with advanced and/or metastatic solid tumors
Wickremsinhe, Enaksha R., Hynes, Scott M., Palmieri, Margo D., Mitchell, Malcolm I., Abraham, Trent L., Rehmel, Jessica Fayer, Chana, Emilie, Jost, Lorenz M., Cassidy, Kenneth C.Volume:
44
Language:
english
Journal:
Xenobiotica
DOI:
10.3109/00498254.2014.900589
Date:
September, 2014
File:
PDF, 946 KB
english, 2014